
As patients explore personalized treatment options, healthcare providers should do the same.
Healthcare treatment is rapidly evolving. Increasing numbers of consumers are showing interest in an approach known as “integrative medicine.” This approach offers new possibilities for enhanced and personalized patient care.
Integrative medicine is not entirely new; its principles are straightforward and sensible. Rather than relying solely on a one-dimensional approach, such as simply “taking this pill three times a day,” integrative medicine suggests that the best healthcare solutions may involve a combination of medications and complementary remedies. These can include a balanced diet, regular exercise, vitamins, and FDA-approved specialty nutraceuticals.
What are specialty nutraceuticals, or medical foods?
Specialty nutraceuticals are dietary products specifically designed to support particular bodily structures or functions. The term broadly refers to any product derived from food sources that provides additional health benefits beyond the basic nutritional value found in foods.
While terms like “exercise” and “vitamins” are commonly understood, “specialty nutraceutical” may be unfamiliar to many in the healthcare field. It’s essential to note that nutraceuticals are not substitutes for traditional drugs or medical treatments; instead, they are part of an integrative approach to support health issues safely and effectively.
What is the difference between a nutraceutical and a medicine?
Pharmaceuticals are FDA-approved drugs specifically designed to treat diseases and provide immediate relief. In contrast, nutraceuticals are nutrient-rich dietary substances derived from whole foods or parts of food sources that offer health benefits beyond basic nutrition.
To learn more, visit the Dietary Supplements Guidance Documents and Regulatory Information page on the FDA’s website.
Doctors and pharmaceutical companies are slow to adapt to specialty nutraceuticals.
Although consumer interest in specialty nutraceuticals is on the rise, many doctors and pharmaceutical companies remain hesitant to embrace them. A recent survey by the American Hospital Association found that 44% of respondents identified “physician resistance” as one of the top three barriers to adopting integrative medicine programs that may include specialty nutraceuticals.
Additionally, some pharmaceutical companies view these supplements not as an opportunity to serve their customers and explore a new revenue stream, but rather as a threat to their existing businesses. This resistance from the pharmaceutical sector is unfortunate, as specialty nutraceuticals offer promising new options for both doctors and patients, as well as a significant market opportunity for these companies.
Although the process may be slow, the specialty nutraceutical market is expected to grow in the coming years, offering patients more solutions and treatment options.
Nutraceuticals occupy a space between food and pharmaceuticals.
They include foods and substances, or combinations of substances, made up of natural molecules or elements. Nutraceuticals are used to maintain or improve health, as well as to treat or prevent diseases and conditions.
To benefit consumers, pharmaceutical companies can take the following steps:
- Recognize the increasing consumer interest in personalized treatments and advocate for these options.
- Consider specialty nutraceuticals as valuable additions to their product lines, providing a clear competitive advantage.
- License patented specialty supplements that are already FDA-approved for manufacturing and distribution in their core markets. Since these products are FDA-approved, research and development costs are minimal, and the time to market is significantly reduced.
- Produce and offer products with substantial profit margins.
- Assist physicians and clinics in refining their treatment protocols, enabling them to differentiate themselves more effectively in the market.
Medical Foods: The concept of personalized treatment has become increasingly relevant.
Medical foods play a crucial role in this emerging standard and perspective. This new approach presents a unique opportunity for large pharmaceutical companies to connect with customers and enhance their profits. Meeting the rising consumer demand aligns with the interests of doctors who wish to provide more options for their patients, as well as pharmaceutical companies looking to strengthen their competitive advantage.